Imai H, Hakkaku N, Iwamoto R, Suzuki J, Suzuki T, Tajima Y, Konishi K, Minami S, Ichinose S, Ishizaka K, et al
A newer high-dose version called Wegovy HD, containing 7.2 mg of semaglutide, was approved for patients whose weight loss stalls on the standard 2.4 mg dose
The integration of personalized wellness approaches has transformed how individuals approach supplementation, with many seeking targeted solutions for specific health goals rather than generic multivitamin approaches
The thigh offers a convenient, accessible injection site with predictable absorption patterns that support consistent weight loss outcomes
48.6% women)
Injection site reactions are localised to where the medication was administered, presenting as redness, itching, or swelling that typically resolves within days